PURPOSE: In addition to bone mineral density (BMD), trabecular microstructure contributes to skeletal strength. Our goal was to examine changes in trabecular microstructure in women on therapy. MATERIALS AND METHODS: We followed 10 postmenopausal women receiving a bisphosphonate, risedronate (35 mg once weekly), over 12 months and examined trabecular microarchitecture with high resolution wrist MR images (hr-MRI). MRI parameters included bone volume/total volume (BV/TV), surface density (representing plates), curve density (representing rods), surface-to-curve ratio and erosion index (depicting deterioration). We assessed BMD of the spine, hip and radius and markers of bone turnover. RESULTS: Women had been receiving bisphosphonate therapy for 43+/-9 months (mean+/-SD) prior to the first MRI. Indices of hr-MRI demonstrated improvement in surface-to-curve ratio (13.0%) and a decrease in erosion index (12.1%) consistent with less deterioration (both p<0.05). BMD of the spine, hip and radius and markers of bone turnover remained stable. Parameters of hr-MRI were associated with 1/3 distal radius BMD (correlation coefficient 0.71 to 0.86, p<0.05). DISCUSSION: We conclude that hr-MRI of the radius demonstrates improvements in trabecular microstructure not appreciated by conventional BMD and provides additional information on parameters that contribute to structural integrity in patients on antiresorptive therapy. Copyright 2010 Elsevier Inc. All rights reserved.
PURPOSE: In addition to bone mineral density (BMD), trabecular microstructure contributes to skeletal strength. Our goal was to examine changes in trabecular microstructure in women on therapy. MATERIALS AND METHODS: We followed 10 postmenopausal women receiving a bisphosphonate, risedronate (35 mg once weekly), over 12 months and examined trabecular microarchitecture with high resolution wrist MR images (hr-MRI). MRI parameters included bone volume/total volume (BV/TV), surface density (representing plates), curve density (representing rods), surface-to-curve ratio and erosion index (depicting deterioration). We assessed BMD of the spine, hip and radius and markers of bone turnover. RESULTS:Women had been receiving bisphosphonate therapy for 43+/-9 months (mean+/-SD) prior to the first MRI. Indices of hr-MRI demonstrated improvement in surface-to-curve ratio (13.0%) and a decrease in erosion index (12.1%) consistent with less deterioration (both p<0.05). BMD of the spine, hip and radius and markers of bone turnover remained stable. Parameters of hr-MRI were associated with 1/3 distal radius BMD (correlation coefficient 0.71 to 0.86, p<0.05). DISCUSSION: We conclude that hr-MRI of the radius demonstrates improvements in trabecular microstructure not appreciated by conventional BMD and provides additional information on parameters that contribute to structural integrity in patients on antiresorptive therapy. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Felix W Wehrli; Punam K Saha; Bryon R Gomberg; Hee Kwon Song; Peter J Snyder; Maria Benito; Alex Wright; Richard Weening Journal: Top Magn Reson Imaging Date: 2002-10
Authors: Marc C Hochberg; Susan Greenspan; Richard D Wasnich; Paul Miller; Desmond E Thompson; Philip D Ross Journal: J Clin Endocrinol Metab Date: 2002-04 Impact factor: 5.958
Authors: D M Black; S R Cummings; D B Karpf; J A Cauley; D E Thompson; M C Nevitt; D C Bauer; H K Genant; W L Haskell; R Marcus; S M Ott; J C Torner; S A Quandt; T F Reiss; K E Ensrud Journal: Lancet Date: 1996-12-07 Impact factor: 79.321
Authors: Babul Borah; Thomas E Dufresne; Paula A Chmielewski; Troy D Johnson; Arkadi Chines; Michael D Manhart Journal: Bone Date: 2004-04 Impact factor: 4.398
Authors: Kuntheavy Ing-Lorenzini; Jules Desmeules; Olivier Plachta; Domizio Suva; Pierre Dayer; Robin Peter Journal: Drug Saf Date: 2009 Impact factor: 5.606
Authors: Henry G Bone; David Hosking; Jean-Pierre Devogelaer; Joseph R Tucci; Ronald D Emkey; Richard P Tonino; Jose Adolfo Rodriguez-Portales; Robert W Downs; Jayanti Gupta; Arthur C Santora; Uri A Liberman Journal: N Engl J Med Date: 2004-03-18 Impact factor: 91.245
Authors: Thomas Baum; Melanie Kutscher; Dirk Müller; Christoph Räth; Felix Eckstein; Eva-Maria Lochmüller; Ernst J Rummeny; Thomas M Link; Jan S Bauer Journal: J Bone Miner Metab Date: 2012-11-22 Impact factor: 2.626
Authors: Susan L Greenspan; Julie Wagner; Joel B Nelson; Subashan Perera; Cynthia Britton; Neil M Resnick Journal: J Bone Miner Res Date: 2013-02 Impact factor: 6.741
Authors: Sandra R Torres; Curtis S K Chen; Brian G Leroux; Peggy P Lee; Lars G Hollender; Michelle Lloid; Shane Patrick Drew; Mark M Schubert Journal: Oral Surg Oral Med Oral Pathol Oral Radiol Date: 2015-02-14
Authors: Dennis T Villareal; John J Kotyk; Reina C Armamento-Villareal; Venkata Kenguva; Pamela Seaman; Allon Shahar; Michael J Wald; Michael Kleerekoper; Luigi Fontana Journal: Aging Cell Date: 2010-11-15 Impact factor: 9.304
Authors: Gregory Chang; Sean Boone; Dimitri Martel; Chamith S Rajapakse; Robert S Hallyburton; Mitch Valko; Stephen Honig; Ravinder R Regatte Journal: J Magn Reson Imaging Date: 2017-02-06 Impact factor: 4.813
Authors: Edmund K Li; Tracy Y Zhu; Vivian Y Hung; Anthony W Kwok; Vivian W Lee; Kenneth K Lee; James F Griffith; Martin Li; Kong Chiu Wong; Ping Chung Leung; Ling Qin; Lai Shan Tam Journal: Arthritis Res Ther Date: 2010-10-22 Impact factor: 5.156
Authors: Thomas Baum; Martin Gräbeldinger; Christoph Räth; Eduardo Grande Garcia; Rainer Burgkart; Janina M Patsch; Ernst J Rummeny; Thomas M Link; Jan S Bauer Journal: J Bone Miner Metab Date: 2013-04-20 Impact factor: 2.626